Tomas D. Bertmark
Directeur/Membre du Conseil chez CanImGuide Therapeutics AB
Postes actifs de Tomas D. Bertmark
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Historique de carrière de Tomas D. Bertmark
Statistiques
Internationale
| Suède | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Bourse
- Insiders
- Tomas D. Bertmark
- Expérience
